
Over The Counter Or OTC Test Market Report 2026
Global Outlook – By Product (Cholesterol Monitoring Test, Urine Analysis Test, Drug Abuse Test, Infectious Disease Testing, Fecal Occult Test, Glucose Monitoring Test), By Application (Cardiology, Glucose Monitoring, Pregnancy And Fertility, Infectious Disease, Toxicology), By End-User (Hospital And Clinic, Home Care, Diagnostic Laboratory, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Over The Counter Or OTC Test Market Overview
• Over The Counter Or OTC Test market size has reached to $27.47 billion in 2025 • Expected to grow to $52.01 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Prevalence Of Chronic Diseases Drives Growth In The Market • Market Trend: Advancements In Over-The-Counter (OTC) Test Kits For Enhanced Health Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Over The Counter Or OTC Test Market?
Over-the-counter (OTC) tests refer to diagnostic tests that can be purchased and used by consumers without a prescription. Over-the-counter (OTC) tests are designed for self-administration by consumers, and they are typically utilized to monitor or assess various aspects of personal health without the need for a doctor's visit. The main product types of over the counter or OTC test are cholesterol monitoring, urine analysis, drug abuse, infectious disease, fecal occult, and glucose monitoring tests. A cholesterol monitoring test measures blood cholesterol and lipid levels to assess heart health and prevent cardiovascular diseases. It is applicable in various applications such as cardiology, oncology, glucose monitoring, pregnancy and fertility, infectious disease, and toxicology. It is used by several end users, including hospitals and clinics, home care, diagnostic laboratories, and others.
What Is The Over The Counter Or OTC Test Market Size and Share 2026?
The over the counter or otc test market size has grown rapidly in recent years. It will grow from $27.47 billion in 2025 to $31.29 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to limited access to diagnostic labs, reliance on in-clinic testing, growing prevalence of chronic diseases, increasing health awareness, adoption of traditional testing methods.What Is The Over The Counter Or OTC Test Market Growth Forecast?
The over the counter or otc test market size is expected to see rapid growth in the next few years. It will grow to $52.01 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to rise in home healthcare adoption, increasing demand for personalized diagnostics, expansion of rapid diagnostic technologies, integration of tests with mobile apps and connected devices, rising consumer preference for convenience and privacy. Major trends in the forecast period include rising adoption of self-testing kits by consumers, growing demand for home-based diagnostics, expansion of rapid diagnostic testing, increasing awareness about preventive healthcare, integration of smart devices with otc tests.Global Over The Counter Or OTC Test Market Segmentation
1) By Product: Cholesterol Monitoring Test, Urine Analysis Test, Drug Abuse Test, Infectious Disease Testing, Fecal Occult Test, Glucose Monitoring Test 2) By Application: Cardiology, Glucose Monitoring, Pregnancy And Fertility, Infectious Disease, Toxicology 3) By End-User: Hospital And Clinic, Home Care, Diagnostic Laboratory, Other End-Users Subsegments: 1) By Cholesterol Monitoring Test: Total Cholesterol Test, HDL (High-Density Lipoprotein) Test, LDL (Low-Density Lipoprotein) Test, Triglycerides Test 2) By Urine Analysis Test: Urine Dipstick Test, Urine Microscopy Test, Urine Culture Test, Urine Pregnancy Test 3) By Drug Abuse Test: Urine Drug Test, Saliva Drug Test, Hair Follicle Drug Test, Breath Drug Test 4) By Infectious Disease Testing: HIV Test, Hepatitis Test, Influenza Test, COVID-19 Test, Strep Throat Test 5) By Fecal Occult Test: Guaiac-Based Fecal Occult Blood Test (gFOBT), Immunochemical Fecal Occult Blood Test (iFOBT/FIT) 6) By Glucose Monitoring Test: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Urine Glucose Test StripsWhat Is The Driver Of The Over The Counter Or OTC Test Market?
Rising prevalence of chronic diseases is expected to propel growth of an over the counter or OTC test market going forward. Chronic diseases refer to long-lasting conditions that persist for a year or more and require ongoing medical attention or limit daily activities. The prevalence of chronic diseases is driven by factors such as an aging population, unhealthy lifestyles, environmental influences, mental health, and socioeconomic status. Over-the-counter (OTC) tests help manage chronic diseases by enabling early detection, empowering patients to monitor their health, and facilitating timely interventions and help to improve health outcomes by promoting proactive care. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it is projected that by the year 2050, the number of individuals aged 50 years and above who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the rising prevalence of chronic diseases is driving growth of an over the counter or OTC test industry.Key Players In The Global Over The Counter Or OTC Test Market
Major companies operating in the over the counter or otc test market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton Dickinson and Company, QuidelOrtho Corporation, Kroger Health, Dexcom Inc., SD Biosensor Inc., OraSure Technologies Inc., Everlywell Inc., LetsGetChecked Inc., Bionime Corporation, Nipro Diagnostics Inc., Chembio Diagnostics Inc., ACON Laboratories Inc., iHealth Labs Inc., Ellume Limited, Geratherm Medical AG, Wondfo Biotech Co. Ltd., bioLytical Laboratories Inc., Watmind USA, First Check Diagnostics LLCGlobal Over The Counter Or OTC Test Market Trends and Insights
Major companies operating in an over the counter or OTC test market are focusing on developing advanced products, such as at-home test kits, to enhance convenience, accuracy, and accessibility for consumers. At-home test kits are designed for personal use, allowing individuals to diagnose specific health conditions or diseases at home. They typically involve collecting samples such as blood, saliva, or urine and provide results quickly. For instance, in December 2023, DiaCarta, a US-based molecular diagnostics company, received its over-the-counter (OTC) iColon Fecal Occult Blood Test (FOBT), following the receipt of US FDA 510(k) clearance. This innovative test enables the early detection of blood in stool, a critical indicator for identifying gastrointestinal disorders and colorectal cancer, the third most prevalent cancer worldwide. The iColon FOBT complements DiaCarta's existing ColoScape Test, further strengthening the company’s commitment to providing advanced healthcare solutions designed to improve early cancer detection and intervention.What Are Latest Mergers And Acquisitions In The Over The Counter Or OTC Test Market?
In December 2024, OraSure Technologies, a US-based medical device company, acquired Sherlock Biosciences for an undisclosed amount. This strategic initiative seeks to strengthen OraSure's diagnostic offerings by incorporating Sherlock's cutting-edge molecular diagnostics platform, which delivers fast, accurate results in a disposable format ideal for home testing. This deal aligns with OraSure's goal to enhance healthcare access and affordability through innovative testing solutions. Sherlock Biosciences is a US-based manufacturer of over-the-counter (OTC) disposable molecular tests for sexually transmitted infections (STIs).Regional Outlook
North America was the largest region in the over the counter or OTC test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Over The Counter Or OTC Test Market?
The over-the-counter (OTC) tests market consists of sales of blood glucose meters, fingerstick cholesterol test kits, skin prick allergy tests, and blood pressure monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Over The Counter Or OTC Test Market Report 2026?
The over the counter or otc test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the over the counter or otc test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Over The Counter Or OTC Test Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $31.29 billion |
| Revenue Forecast In 2035 | $52.01 billion |
| Growth Rate | CAGR of 13.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton Dickinson and Company, QuidelOrtho Corporation, Kroger Health, Dexcom Inc., SD Biosensor Inc., OraSure Technologies Inc., Everlywell Inc., LetsGetChecked Inc., Bionime Corporation, Nipro Diagnostics Inc., Chembio Diagnostics Inc., ACON Laboratories Inc., iHealth Labs Inc., Ellume Limited, Geratherm Medical AG, Wondfo Biotech Co. Ltd., bioLytical Laboratories Inc., Watmind USA, First Check Diagnostics LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
